FANTOM Post Market Clinical Trial
This study, called FANTOM, is exploring a new kind of dissolving stent for people who have narrowed or blocked heart arteries, a condition known as coronary artery disease. This particular device, named Fantom, slowly dissolves in your body after it has done its job of keeping the artery open. This study isn't a brand new treatment test, but rather a "post-market" check. This means the device is already in use, and researchers are gathering more information on its long-term safety and effectiveness in a wider patient group. They want to understand how well it helps patients in real-world settings and continue to monitor its performance. It's designed to be a comprehensive look at how patients recover and live their lives after having the Fantom device implanted.
At a glance
What is this study about?
Heart disease, specifically coronary artery disease, happens when the blood vessels that supply your heart become narrowed or blocked, often due to a build-up of fatty substances. This can lead to chest pain (angina) or, in more serious cases, a heart attack. To help blood flow more freely to the heart, doctors sometimes use a small tube-like device called a stent to prop open the narrowed artery. Traditionally, these stents are made of metal and stay in your body permanently.
This study focuses on a newer type of stent called a bioresorbable scaffold, specifically the Fantom device. The key difference is that this scaffold is designed to gradually dissolve and disappear in your body over time, once the artery is strong enough to stay open on its own. The idea is that once the artery has healed and remodelled, there's no permanent foreign object left inside. This post-market study aims to collect more information on how well the Fantom scaffold works in a real-world setting, examining its long-term safety and effectiveness in patients who have already received it.
By carefully tracking patients who have had the Fantom scaffold, researchers can gather valuable information about how people recover, how their arteries respond, and whether this dissolving support continues to improve their health in the long run. This information helps doctors understand the best ways to care for patients with coronary artery disease and continuously improve treatment options.
Key takeaways
- This study is observing a new type of dissolvable stent for blocked heart arteries.
- It's a 'post-market' study, gathering long-term information on an already approved device.
- The Fantom stent dissolves over time, leaving no permanent implant.
- Participation involves routine medical care and allowing researchers to collect health information.
- It aims to improve future treatments for coronary artery disease.
- You can withdraw from the study at any point without impacting your care.
Who may be eligible?
To join this study, you need to be at least 18 years old and have been diagnosed with coronary artery disease, meaning you have evidence of reduced blood flow to your heart. Your doctor must also think that treatment with a stent is a suitable option for you, and that you would be able to have emergency bypass surgery if needed. You also need to be able to attend all the follow-up appointments and be happy to give your written permission to take part.
There are also specific requirements for the narrowed artery itself. For example, it needs to be a new blockage, and the narrowing must be between 50% and less than 100%. The artery also needs to be a certain size, and there should be no significant complications during the initial procedure to place the stent. You mustn't be experiencing ongoing chest pain or certain heart rhythm changes at the time.
However, you won't be able to join if you have certain allergies, such as to aspirin or the dyes used in procedures. You also can't have had a major heart attack within the last 72 hours with certain blood test results still high, or if your heart's pumping ability (ejection fraction) is very low (less than 30%). Other reasons for not being able to join include severe blockages in the main heart artery that supplies blood to the left side of your heart, or if you've had a stent in the same artery in the last year.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you at least 18 years old?
- Do you have narrowing in one of your heart's arteries?
- Are you able to attend all planned follow-up appointments?
- Can you safely take medicines like aspirin?
- Have you had a major heart attack in the last 72 hours?
- Do you have very severe blockages in your main heart artery?
What does participation involve?
This study is a "post-market" study, meaning the Fantom device is already in use. If you are eligible and decide to take part, you would receive the Fantom device as part of your normal medical care for coronary artery disease. Your participation primarily involves allowing the research team to collect information about your health and recovery from your medical records and during your routine follow-up appointments. This will include details about the procedure itself, how you feel afterwards, and any further treatments you might need. You would need to commit to attending all specified follow-up evaluations as requested by the study, which could involve doctor's visits and potentially some tests like angiograms (X-rays of your blood vessels). The total duration of your involvement in the study would depend on the follow-up schedule set by the researchers, which is usually for a number of years to track long-term health, but specific timings would be discussed with you by your doctor.
Potential risks and benefits
Locations (10)
- WilhelminenhospitalVerified postcodeVienna, Austria· Recruiting
- Juedisches Krankenhaus BerlinVerified postcodeBerlin, Germany· Recruiting
- Technische Universitat DresdenVerified postcodeDresden, Germany· Recruiting
- Universitatsklinikum HalleVerified postcodeHalle, Germany· Recruiting
- Klinikum HerfordVerified postcodeHerford, Germany· Recruiting
- Universitatsklinikum Schleswig-Holstein, Campus KielVerified postcodeKiel, Germany· Recruiting
- Clemenshospital MuensterVerified postcodeMünster, Germany· Recruiting
- Klinkum OldenburgVerified postcodeOldenburg, Germany· Recruiting
- Marien Hospital WittenVerified postcodeWitten, Germany· Recruiting
- University Kantonsspital BasellandVerified postcodeLiestal, Switzerland· Recruiting
Common questions
What is a 'post-market' study?
It means the treatment (Fantom stent) is already approved and in use, and this study is gathering more information on its long-term safety and how well it works in real patients.
What is a bioresorbable scaffold?
It's a type of stent that is designed to dissolve away in your body over time, unlike traditional metal stents that stay in permanently.
What is coronary artery disease?
It's a condition where the blood vessels supplying your heart become narrowed or blocked, reducing blood flow to the heart muscle.
Will I get special treatment if I join?
You will receive the Fantom device as part of your standard care, and your health will be carefully monitored as part of the study.
Can I leave the study if I change my mind?
Yes, you can withdraw from the study at any time, and this will not affect the medical care you receive from your doctors.
How to find out more
Jeffrey Anderson
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.